Biotricity Statistics

Total Valuation

Biotricity has a market cap or net worth of 9.71 million. The enterprise value is 36.76 million.

Market Cap	9.71M
Enterprise Value	36.76M

Important Dates

The next estimated earnings date is Friday, June 27, 2025.

Earnings Date	Jun 27, 2025
Ex-Dividend Date	n/a

Share Statistics

Biotricity has 26.24 million shares outstanding. The number of shares has increased by 96.22% in one year.

Current Share Class	26.08M
Shares Outstanding	26.24M
Shares Change (YoY)	+96.22%
Shares Change (QoQ)	+7.73%
Owned by Insiders (%)	28.12%
Owned by Institutions (%)	n/a
Float	18.04M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.73
PB Ratio	-0.34
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.57
EV / Sales	2.77
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.23

Current Ratio	0.23
Quick Ratio	0.16
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-0.83

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-50.53%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	30.60%
Revenue Per Employee	241,200
Profits Per Employee	-260,363
Employee Count	55
Asset Turnover	2.31
Inventory Turnover	1.88

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -58.43% in the last 52 weeks. The beta is 1.23, so Biotricity's price volatility has been higher than the market average.

Beta (5Y)	1.23
52-Week Price Change	-58.43%
50-Day Moving Average	0.48
200-Day Moving Average	0.40
Relative Strength Index (RSI)	34.76
Average Volume (20 Days)	44,156

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.51

Income Statement

In the last 12 months, Biotricity had revenue of 13.27 million and -14.32 million in losses. Loss per share was -0.83.

Revenue	13.27M
Gross Profit	9.86M
Operating Income	-4.64M
Pretax Income	-10.67M
Net Income	-14.32M
EBITDA	-4.63M
EBIT	-4.64M
Loss Per Share	-0.83

Full Income Statement

Balance Sheet

The company has 2.06 million in cash and 25.46 million in debt, giving a net cash position of -23.40 million or -0.89 per share.

Cash & Cash Equivalents	2.06M
Total Debt	25.46M
Net Cash	-23.40M
Net Cash Per Share	-0.89
Equity (Book Value)	-28.29M
Book Value Per Share	-1.30
Working Capital	-16.28M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-3.15M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 74.31%, with operating and profit margins of -34.96% and -80.42%.

Gross Margin	74.31%
Operating Margin	-34.96%
Pretax Margin	-80.42%
Profit Margin	-80.42%
EBITDA Margin	-34.92%
EBIT Margin	-34.96%
FCF Margin	n/a

Dividends & Yields

Biotricity does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-96.22%
Shareholder Yield	n/a
Earnings Yield	-147.48%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 3, 2023. It was a reverse split with a ratio of 0.1666667.

Last Split Date	Jul 3, 2023
Split Type	Reverse
Split Ratio	0.1666667

Scores

Biotricity has an Altman Z-Score of -35.54 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-35.54
Piotroski F-Score	4